SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Human Genome Sciences, Inc. (HGSI)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1127 105 0 HGSI
Emcee:  Jeffrey Ogbar Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
952A little surprised no one has commented on the VaxGen blowup. Their anthrax protuck-12/22/2006
951xml.10kwizard.combob zagorin-12/21/2006
950Human Genome Sciences Initiates Phase 3 Clinical Trial of Albuferon(R) in Combinbob zagorin-12/19/2006
949Human Genome Sciences had higher quarterly revenue from drug development deals wtom pope-11/8/2006
948Merrill: Upbeat Analyst Day focusing on transition to phase III HGSI focused ontom pope-10/5/2006
947A little background: posts #408 and #412 (mine) from 2/16/2000 << Human Steven Rachbach-10/2/2006
946The field might not be as crowded as all that. Most of the competing CCR5 antagtuck-10/2/2006
945Tuck, Well, all the study showed was that their first anti-CCR5 antibody has soSteven Rachbach-10/2/2006
944Any thoughts about this anti-CCR5 program for HIV? Message 22870216 Safety lootuck-10/2/2006
943TRAIL-based therapies danger to livers; bad news for HGSI and others like CATG: tuck-9/6/2006
942george soros discloses new 280,000 share investmnet in hgsi along with several obob zagorin-8/16/2006
941GS Human Genome Sciences, Inc. EPS (FY Dec) 2006E ($1.31), 2007E ($2.12) In-Linbob zagorin-8/10/2006
940Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2006 bob zagorin-8/3/2006
939HHS Buying Anthrax Treatments Friday July 28, 2:58 pm ET HHS Buying 10,000 Anti-bob zagorin-7/28/2006
9388:41 AM ET 06/22/06 UPDATE 1-Human Genome says lupus drug shows promise (Adds bob zagorin-6/23/2006
937Target Price Updates Symbol Broker From To Date HGSI Piper Jaffray bob zagorin-6/23/2006
936GS today Human Genome Sciences, Inc. EPS (FY Dec) 2006E ($2.10), 2007E ($2.12) bob zagorin-6/21/2006
935from zacks.. EPS Estimate Revisions Symbol Broker Revision Period Period Enbob zagorin-6/21/2006
934ML's take on todays news (ML has it as a buy): US Government orders 20,000 tom pope-6/20/2006
933What the chance that the departure of ANDS’ CEO is <i>not</i> relateDewDiligence_on_SI-6/14/2006
932Decoding Human Genome's Stock [WSJ]: investorshub.comDewDiligence_on_SI-6/14/2006
931Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at bob zagorin-6/12/2006
930Human Genome Sciences Completes Transaction Establishing CoGenesys as an Indepenbob zagorin-6/12/2006
929Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at bob zagorin-6/9/2006
928from zacks Target Price Updates Symbol Broker From To Date HGSI Robbob zagorin-6/9/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News